ebomi
Colour theme
Sign in
Insider · CIK 0001853723

Sr ONE Capital Management, LLC

CIK 0001853723 Name as filed on the most recent filing

Filed as Sr ONE Capital Management, LLC (9)

25 transaction lines · from 9 filings · filed 2021-04-01 to 2026-05-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		S, Open-market sale 1,065 disposed 18.00 19,170.00 Form 4, filing 0001193125-26-217656
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		S, Open-market sale 438 disposed 18.00 7,884.00 Form 4, filing 0001193125-26-217656
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		S, Open-market sale 277 disposed 18.00 4,986.00 Form 4, filing 0001193125-26-217656
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		P, Open-market purchase 222,222 acquired 18.00 3,999,996.00 Form 4, filing 0001193125-26-217656
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		P, Open-market purchase 200,000 acquired 18.00 3,600,000.00 Form 4, filing 0001193125-26-217656
2026-05-11 Odyssey Therapeutics, Inc.
ODTX 		P, Open-market purchase 133,333 acquired 18.00 2,399,994.00 Form 4, filing 0001193125-26-217656
2026-05-01 Avalyn Pharma Inc.
AVLN 		P, Open-market purchase 277,778 acquired 18.00 5,000,004.00 Form 4, filing 0001193125-26-201887
2026-05-01 Avalyn Pharma Inc.
AVLN 		P, Open-market purchase 277,777 acquired 18.00 4,999,986.00 Form 4, filing 0001193125-26-201887
2025-10-09 Zenas BioPharma, Inc.
ZBIO 		P, Open-market purchase 63,158 acquired 19.00 1,200,002.00 Form 4, filing 0001193125-25-239153
2025-10-09 Zenas BioPharma, Inc.
ZBIO 		P, Open-market purchase 63,157 acquired 19.00 1,199,983.00 Form 4, filing 0001193125-25-239153
2024-09-16 Zenas BioPharma, Inc.
ZBIO 		P, Open-market purchase 1,352,942 acquired 17.00 23,000,014.00 Form 4, filing 0000950170-24-106978
2024-09-16 Zenas BioPharma, Inc.
ZBIO 		P, Open-market purchase 441,176 acquired 17.00 7,499,992.00 Form 4, filing 0000950170-24-106978
2024-09-16 Zenas BioPharma, Inc.
ZBIO 		P, Open-market purchase 441,176 acquired 17.00 7,499,992.00 Form 4, filing 0000950170-24-106978
2023-11-27 eFFECTOR Therapeutics, Inc.
EFTR 		S, Open-market sale 430,578 disposed 0.61 261,145.56 Form 4, filing 0001209191-23-056920
2023-11-27 eFFECTOR Therapeutics, Inc.
EFTR 		S, Open-market sale 178,585 disposed 0.61 108,311.80 Form 4, filing 0001209191-23-056920
2023-05-11 Arcellx, Inc.
ACLX 		S, Open-market sale 631,932 disposed 45.00 28,436,940.00 Form 4, filing 0001209191-23-029610
2023-05-11 Arcellx, Inc.
ACLX 		S, Open-market sale 370,612 disposed 45.00 16,677,540.00 Form 4, filing 0001209191-23-029610
2023-05-11 Arcellx, Inc.
ACLX 		S, Open-market sale 6,485 disposed 46.15 299,282.75 Form 4, filing 0001209191-23-029610
2023-05-11 Arcellx, Inc.
ACLX 		S, Open-market sale 3,804 disposed 46.15 175,554.60 Form 4, filing 0001209191-23-029610
2022-12-20 Design Therapeutics, Inc.
DSGN 		P, Open-market purchase 40,000 acquired 8.14 325,432.00 Form 4, filing 0001209191-22-062226
2022-12-19 Design Therapeutics, Inc.
DSGN 		P, Open-market purchase 360,000 acquired 8.63 3,108,096.00 Form 4, filing 0001209191-22-062226
2022-12-16 Design Therapeutics, Inc.
DSGN 		P, Open-market purchase 500,000 acquired 8.28 4,140,550.00 Form 4, filing 0001209191-22-062226
2022-02-08 Arcellx, Inc.
ACLX 		P, Open-market purchase 1,600,000 acquired 15.00 24,000,000.00 Form 4, filing 0001209191-22-008281
2022-02-08 Arcellx, Inc.
ACLX 		P, Open-market purchase 66,667 acquired 15.00 1,000,005.00 Form 4, filing 0001209191-22-008281
2021-03-30 Design Therapeutics, Inc.
DSGN 		P, Open-market purchase 250,000 acquired 20.00 5,000,000.00 Form 4, filing 0001209191-21-024238

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. SR ONE CAPITAL MANAGEMENT, LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001853723

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.